Janus Henderson Group Ltd.

13D and 13G Filings

Issuer % of Class Filed
Korsana Biosciences, Inc. 13G
KRSA · 23255M303
5.2% 11/16/2026
Event 9/30/2026
Blossomhill Therapeutics, Inc. 13G
BLSM · 095130100
7.8% 11/16/2026
Event 9/30/2026
Titan Machinery Inc. 13G
TITN · 88830R101
5.0% 11/16/2026
Event 9/30/2026
Napco Security Technologies, Inc. 13G
NSSC · 630402105
5.1% 11/16/2026
Event 9/30/2026
Anterix Inc. 13G
ATEX · 03676C100
5.3% 11/16/2026
Event 9/30/2026
Definium Therapeutics, Inc. 13G
DFTX · 24477V105
5.4% 11/16/2026
Event 9/30/2026
Central Garden & Pet Co 13G
CENT · 153527106
7.3% 11/16/2026
Event 9/30/2026
Newamsterdam Pharma N.V. 13G
NAMS · N62509109
7.5% 11/16/2026
Event 9/30/2026
Tenax Therapeutics, Inc. 13G/A Amendment 1
TENX · 88032L605
0% 11/16/2026
Event 9/30/2026
Protara Therapeutics, Inc. 13G/A Amendment 8
TARA · 74365U107
0% 11/16/2026
Event 9/30/2026
Longeveron Inc. 13G/A Amendment 1
LGVN · 54303L203
4.4% 11/16/2026
Event 9/30/2026
Ligand Pharmaceuticals Incorporated 13G/A Amendment 10
LGND · 53220K504
4.6% 11/16/2026
Event 9/30/2026
Assembly Biosciences, Inc. 13G/A Amendment 2
ASMB · 045396207
3.3% 11/16/2026
Event 9/30/2026
Collegium Pharmaceutical, Inc. 13G/A Amendment 1
COLL · 19459J104
0.2% 11/16/2026
Event 9/30/2026
Biohaven Ltd. 13G/A Amendment 4
BHVN · G1110E107
1.4% 11/16/2026
Event 9/30/2026
Yarrow Bioscience, Inc. 13G/A Amendment 1
YARW · 92941V407
3.0% 11/16/2026
Event 9/30/2026
Rentokil Initial PLC 13G/A Amendment 5
RKLIF · G7494G105
3.3% 11/16/2026
Event 9/30/2026
Revolution Medicines, Inc. 13G/A Amendment 1
RVMD · 76155X100
3.5% 11/16/2026
Event 9/30/2026
DraftKings Inc. 13G/A Amendment 1
DKNG · 26142V105
4.2% 11/16/2026
Event 9/30/2026
Lantheus Holdings, Inc. 13G/A Amendment 9
LNTH · 516544103
4.2% 11/16/2026
Event 9/30/2026
Contineum Therapeutics, Inc. 13G/A Amendment 1
CTNM · 21217B100
4.6% 11/16/2026
Event 9/30/2026
Mirum Pharamaceuticals, Inc. 13G/A Amendment 11
MIRM · 604749101
8.5% 11/16/2026
Event 9/30/2026
Monopar Therapeutics Inc. 13G/A Amendment 5
MNPR · 61023L207
16.7% 11/16/2026
Event 9/30/2026
Lexeo Therapeutics, Inc. 13G/A Amendment 8
LXEO · 52886X107
7.2% 11/16/2026
Event 9/30/2026
Revvity, Inc. 13G/A Amendment 3
RVTY · 714046109
6.6% 11/16/2026
Event 9/30/2026
Edgewise Therapeutics, Inc. 13G/A Amendment 1
EWTX · 28036F105
6.7% 11/16/2026
Event 9/30/2026
Olema Pharmaceuticals, Inc. 13G/A Amendment 3
OLMA · 68062P106
7.2% 11/16/2026
Event 9/30/2026
Glaukos Corp 13G/A Amendment 2
GKOS · 377322102
7.9% 11/16/2026
Event 9/30/2026
WEX, Inc. 13G/A Amendment 13
WEX · 96208T104
8.6% 11/16/2026
Event 9/30/2026
Surgery Partners, Inc. 13G/A Amendment 4
SGRY · 86881A100
4.9% 11/6/2026
Event 10/30/2026
Eyepoint, Inc. 13G
EYPT · 30233G209
10.9% 9/8/2026
Event 8/31/2026
Vogenx, Inc. 13G
VOGX · 92859A106
13.0% 9/8/2026
Event 8/31/2026
Teleflex Incorporated 13G/A Amendment 6
TFX · 879369106
10.3% 9/8/2026
Event 8/31/2026
Ziff Davis, Inc. 13G/A Amendment 9
ZD · 48123V102
10.3% 9/8/2026
Event 8/31/2026
Mirum Pharamaceuticals, Inc. 13G/A Amendment 10
MIRM · 604749101
9.7% 8/13/2026
Event 6/30/2026
Forte Biosciences, Inc. 13G/A Amendment 5
FBRX · 34962G208
9.3% 8/13/2026
Event 6/30/2026
Assembly Biosciences, Inc. 13G/A Amendment 1
ASMB · 045396207
6.9% 8/13/2026
Event 6/30/2026
Tarsus Pharmaceuticals, Inc. 13G/A Amendment 1
TARS · 87650L103
6.5% 8/13/2026
Event 6/30/2026
Dyne Therapeutics, Inc. 13G/A Amendment 7
DYN · 26818M108
7.3% 8/13/2026
Event 6/30/2026
Protara Therapeutics, Inc. 13G/A Amendment 7
TARA · 74365U107
8.4% 8/13/2026
Event 6/30/2026
Ziff Davis, Inc. 13G/A Amendment 8
ZD · 48123V102
9.7% 8/13/2026
Event 6/30/2026
ICU Medical, Inc. 13G/A Amendment 12
ICUI · 44930G107
11.1% 8/13/2026
Event 6/30/2026
Immix Biopharma, Inc. 13G/A Amendment 3
IMMX · 45258H106
14.0% 8/13/2026
Event 6/30/2026
Janux Therapeutics, Inc. 13G/A Amendment 6
JANX · 47103J105
0.3% 8/13/2026
Event 6/30/2026
Flex Ltd. 13G/A Amendment 8
FLEX · Y2573F102
3.8% 8/13/2026
Event 6/30/2026
Bicara Therapeutics Inc. 13G/A Amendment 1
BCAX · 055477103
4.8% 8/13/2026
Event 6/30/2026
Bel Fuse Inc. 13G/A Amendment 2
BELFB · 077347300
4.8% 8/13/2026
Event 6/30/2026
Ocugen, Inc. 13G/A Amendment 1
OCGN · 67577C105
3.0% 8/13/2026
Event 6/30/2026
Revolution Medicines, Inc. 13G
RVMD · 76155X100
5.1% 8/13/2026
Event 6/30/2026
Achieve Life Sciences, Inc. 13G
ACHV · 004468500
5.4% 8/13/2026
Event 6/30/2026
Inspired Entertainment, Inc. 13G
INSE · 45782N108
5.0% 8/13/2026
Event 6/30/2026
LPL Financial Holdings Inc. 13G
LPLA · 50212V100
5.3% 8/13/2026
Event 6/30/2026
OSI Systems, Inc. 13G
OSIS · 671044105
5.5% 8/13/2026
Event 6/30/2026
Jatt II Acquisition Corp. 13G
JATT · G50765109
6.2% 8/13/2026
Event 6/30/2026
Vaxcyte, Inc. 13G/A Amendment 11
PCVX · 92243G108
12.1% 8/11/2026
Event 7/31/2026
Yarrow Bioscience, Inc. 13G
YARW · 92941V407
10.0% 8/7/2026
Event 7/31/2026
Vaxcyte, Inc. 13G/A Amendment 10
PCVX · 92243G108
0.1% 8/7/2026
Event 7/31/2026
Forte Biosciences, Inc. 13G/A Amendment 6
FBRX · 34962G208
2.5% 8/7/2026
Event 7/31/2026
Privacore VPC Asset Backed Credit Fund 13G
74291E300
17.1% 7/8/2026
Event 6/30/2026
Privacore Pcaam Alternative Growth Fund 13G
74290Y307
46.8% 7/8/2026
Event 6/30/2026
Privacore Pcaam Alternative Income Fund 13G
74291A308
67.4% 7/8/2026
Event 6/30/2026
Biohaven Ltd. 13G/A Amendment 2
BHVN · G1110E107
5.7% 7/8/2026
Event 6/30/2026
Jade Biosciences, Inc. 13G/A Amendment 2
JBIO · 008064206
10.6% 7/8/2026
Event 6/30/2026
Cellectar Biosciences, Inc. 13G
CLRB · 15117F880
10.0% 6/5/2026
Event 5/29/2026
Immix Biopharma, Inc. 13G/A Amendment 2
IMMX · 45258H106
13.0% 6/5/2026
Event 5/29/2026
Tyra Biosciences, Inc. 13G/A Amendment 2
TYRA · 90240B106
7.2% 5/15/2026
Event 3/31/2026
PTC Therapeutics, Inc. 13G/A Amendment 1
PTCT · 69366J200
8.7% 5/15/2026
Event 3/31/2026
Protara Therapeutics, Inc. 13G/A Amendment 6
TARA · 74365U107
9.6% 5/15/2026
Event 3/31/2026
Olema Pharmaceuticals, Inc. 13G/A Amendment 2
OLMA · 68062P106
8.2% 5/15/2026
Event 3/31/2026
Lantheus Holdings, Inc. 13G/A Amendment 8
LNTH · 516544103
7.4% 5/15/2026
Event 3/31/2026
Janux Therapeutics, Inc. 13G/A Amendment 5
JANX · 47103J105
6.9% 5/15/2026
Event 3/31/2026
Jade Biosciences, Inc. 13G/A Amendment 1
JBIO · 008064206
6.3% 5/15/2026
Event 3/31/2026
Immix Biopharma, Inc. 13G/A Amendment 1
IMMX · 45258H106
9.1% 5/15/2026
Event 3/31/2026
Vaxcyte, Inc. 13G/A Amendment 9
PCVX · 92243G108
11.5% 5/15/2026
Event 3/31/2026
Maze Therapeutics, Inc. 13G/A Amendment 3
MAZE · 578784100
5.8% 5/15/2026
Event 3/31/2026
Madrigal Pharmaceuticals, Inc. 13G/A Amendment 9
MDGL · 558868105
8.8% 5/15/2026
Event 3/31/2026
IDEAYA Biosciences, Inc. 13G/A Amendment 6
IDYA · 45166A102
8.3% 5/15/2026
Event 3/31/2026
Biohaven Ltd. 13G/A Amendment 2
BHVN · G1110E107
11.7% 5/15/2026
Event 3/31/2026
Glaukos Corp 13G/A Amendment 1
GKOS · 377322102
9.2% 5/15/2026
Event 3/31/2026
Gildan Activewear Inc 13G/A Amendment 4
GIL · 375916103
5.7% 5/15/2026
Event 3/31/2026
Forte Biosciences, Inc. 13G/A Amendment 4
FBRX · 34962G208
10.0% 5/15/2026
Event 3/31/2026
Dyne Therapeutics, Inc. 13G/A Amendment 6
DYN · 26818M108
8.3% 5/15/2026
Event 3/31/2026
Bright Minds Biosciences Inc. 13G/A Amendment 4
DRUG · 10919W405
13.1% 5/15/2026
Event 3/31/2026
Bright Minds Biosciences Inc. 13G/A Amendment 4
DRUG · 10919W405
13.1% 5/15/2026
Event 3/31/2026
BridgeBio Pharma, Inc. 13G/A Amendment 1
BBIO · 10806X102
6.8% 5/15/2026
Event 3/31/2026
Bel Fuse Inc. 13G/A Amendment 1
BELFB · 077347300
7.2% 5/15/2026
Event 3/31/2026
Ascendis Pharma A/S 13G/A Amendment 9
ASND · 04351P101
6.0% 5/15/2026
Event 3/31/2026
Minerva Neurosciences, Inc 13G
NERV · 603380205
9.9% 5/15/2026
Event 3/31/2026
Longeveron Inc. 13G
LGVN · 54303L203
5.9% 5/15/2026
Event 3/31/2026
Bicara Therapeutics Inc. 13G
BCAX · 055477103
5.1% 5/15/2026
Event 3/31/2026
Tarsus Pharmaceuticals, Inc. 13G
TARS · 87650L103
5.3% 5/15/2026
Event 3/31/2026
Stride, Inc. 13G
LRN · 86333M108
5.4% 5/15/2026
Event 3/31/2026
Edgewise Therapeutics, Inc. 13G
EWTX · 28036F105
5.5% 5/15/2026
Event 3/31/2026
Collegium Pharmaceutical, Inc. 13G
COLL · 19459J104
5.8% 5/15/2026
Event 3/31/2026
Dayforce, Inc. 13G/A Amendment 2
DAY · 15677J108
0% 5/15/2026
Event 3/31/2026
Ardelyx, Inc. 13G/A Amendment 9
ARDX · 039697107
3.4% 5/15/2026
Event 3/31/2026
OSI Systems, Inc. 13G/A Amendment 13
OSIS · 671044105
4.7% 5/15/2026
Event 3/31/2026
Revolution Medicines, Inc. 13G/A Amendment 4
RVMD · 76155X100
4.9% 5/15/2026
Event 3/31/2026
Xenon Pharmaceuticals Inc. 13G/A Amendment 1
XENE · 98420N105
4.5% 5/15/2026
Event 3/31/2026
SS&C Technologies Holdings, Inc 13G/A Amendment 14
SSNC · 78467J100
3.5% 5/15/2026
Event 3/31/2026

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.